Brief: Robigo And Leaps By Bayer Announce Series A Financing To Advance Engineered Biologicals
17/09/2026 14:11
BRIEF-Robigo And Leaps By Bayer Announce Series A Financing To Advance Engineered Biologicals Sept 17 (Reuters) - Bayer AG BAYGn.DE:
ROBIGO AND LEAPS BY BAYER ANNOUNCE SERIES A FINANCING TO ADVANCE ENGINEERED BIOLOGICALS THAT PROTECT YIELDS AND REDUCE COSTS
ROBIGO: FUNDING WITH PARTICIPATION FROM ILLUMINA VENTURES, SVG THRIVE, CONGRUENT VENTURES, AND ENDEAVOR8
Source text: ID:nBw2zq4cba
Further company coverage: [BAYGn.DE]
(Gdansk Newsroom)
((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));;))
Recent news on Illumina
See all newsBrief: Illumina Bioinsight Platform Expands With New Software To Accelerate The Path From Sequencing To Discovery
US RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Brief: Illumina - Establishes Unsecured Commercial Paper Program On October 8, 2026
Brief: Illumina To Announce Third Quarter 2026 Financial Results
Brief: Illumina Releases Spliceai2 To Help Advance Rare Disease Research